Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin.BackgroundAnemia in patients with end-stage renal disease (ESRD) is treated with recombinant human erythropoietin (rhEPO) often in combination with iron. However, iron catalyzes the formation of toxic radicals, which might promote vascular damage, is a nutrient for microorganisms, and negatively affects immune pathways, thus increasing the risk for severe infections.MethodsWe investigated 28 patients on chronic hemodialysis who were randomized to receive either rhEPO alone (N = 15) or rhEPO in combination with intravenous iron (N = 13) for a period of 12weeks. We analyzed iron therapy associated changes in cytokine patterns an...
Erythropoiesis-stimulating agents (ESA) are used to treat anemia in hemodialysis (HD) patients. We i...
<div><p>Background</p><p>We aimed to identify associations between erythroferrone (ERFE), a regulato...
Iron deficiency anemia is a common complication in end-stage renal disease (ESRD) and impairs the th...
In patients with chronic kidney disease, treatment with erythropoiesis-stimulating agents (ESA) effe...
Iron overload increases the risk of bacterial infection in dialysis patients, partly by impairing fu...
Introduction Intravenous iron in combination with erythropoietin therapy is essential in maintainin...
Background&Objective: Decrease in production of erythropoietin has been noted as one of the main fac...
Iron and infection. Intravenous iron therapy maintains iron stores and decreases erythropoietin dema...
Inflammation induced anemia and resistance to erythropoietin are common features in patients with ch...
Patients with chronic kidney disease (CKD), especially those requiring maintenance hemodialysis trea...
Iron is a very important biogenous trace element, which is involved in many of cell processes in org...
Anaemia is a common complication in haemodialysis patients. This condition is associated to a decre...
Patients with chronic kidney disease (CKD) are at increased risk for infection, attributable to immu...
BACKGROUND:Elements of malnutrition-inflammation complex syndrome (MICS) may blunt the responsivenes...
Erythropoietin hyporesponsiveness: From iron deficiency to iron overload. Iron deficiency is the mos...
Erythropoiesis-stimulating agents (ESA) are used to treat anemia in hemodialysis (HD) patients. We i...
<div><p>Background</p><p>We aimed to identify associations between erythroferrone (ERFE), a regulato...
Iron deficiency anemia is a common complication in end-stage renal disease (ESRD) and impairs the th...
In patients with chronic kidney disease, treatment with erythropoiesis-stimulating agents (ESA) effe...
Iron overload increases the risk of bacterial infection in dialysis patients, partly by impairing fu...
Introduction Intravenous iron in combination with erythropoietin therapy is essential in maintainin...
Background&Objective: Decrease in production of erythropoietin has been noted as one of the main fac...
Iron and infection. Intravenous iron therapy maintains iron stores and decreases erythropoietin dema...
Inflammation induced anemia and resistance to erythropoietin are common features in patients with ch...
Patients with chronic kidney disease (CKD), especially those requiring maintenance hemodialysis trea...
Iron is a very important biogenous trace element, which is involved in many of cell processes in org...
Anaemia is a common complication in haemodialysis patients. This condition is associated to a decre...
Patients with chronic kidney disease (CKD) are at increased risk for infection, attributable to immu...
BACKGROUND:Elements of malnutrition-inflammation complex syndrome (MICS) may blunt the responsivenes...
Erythropoietin hyporesponsiveness: From iron deficiency to iron overload. Iron deficiency is the mos...
Erythropoiesis-stimulating agents (ESA) are used to treat anemia in hemodialysis (HD) patients. We i...
<div><p>Background</p><p>We aimed to identify associations between erythroferrone (ERFE), a regulato...
Iron deficiency anemia is a common complication in end-stage renal disease (ESRD) and impairs the th...